Corcept Therapeutics | CORT - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Alaunos Therapeutics USD 400K 213K 2026-03
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Assertio Holdings USD 14.66M 3.81M 2025-09
Aurora Cannabis CAD 68.03M 18.68M 2025-12
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 68.41M 3.34M 2026-03
J&J USD 10.46B 1.53B 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.46B 99M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 4.51B 734M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03